跳至主要内容
临床试验/CTRI/2026/07/113895
CTRI/2026/07/113895进行中(未招募)不适用

Evaluating the Efficacy of Personalised Yoga in Reducing Constipation and Improving Quality of Life in Cancer Patients Receiving Palliative Care: A Randomized Controlled Trial - NIL

Advanced Centre for Treatment Research and Education in Cancer0 个研究点目标入组 100 人开始时间: 2026年7月27日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adults more than equal to 18 years
  • Histologically confirmed diagnosis of cancer and receiving palliative care for it
  • Patients diagnosed with constipation, as defined in the Study Population section, with
  • symptoms present for at least 2 weeks prior to screening.
  • Estimated life expectancy more than equal to 6 months as estimated by their treating oncologist
  • Performance Status or ECOG less than equal to 2
  • Medically fit to participate in low-intensity physical activity, as determined by the
  • treating physician.
  • Ability to demonstrate the Yoga Intervention appropriately which would be assessed
  • by the Yoga Instructor.
  • Able and willing to provide written informed consent
  • Willing to comply with the yoga intervention and study assessments

排除标准

  • Evidence of mechanical bowel obstruction or complete bowel obstruction.
  • Active symptomatic or bleeding hemorrhoids within the past 4 weeks, or current
  • hemorrhoids likely to worsen with yoga postures or abdominal strain.
  • History or current diagnosis of herniated disc or spinal cord disease.
  • Cognitive impairment or active psychiatric illness that would interfere with providing
  • informed consent or adhering to the study protocol.
  • Recent abdominal surgery (within the past 3 months).
  • Known severe cardiorespiratory or musculoskeletal limitations contraindicating yoga
  • (e.g., NYHA III IV heart failure, unstable angina, advanced COPD [GOLD stage III IV],
  • severe arthritis causing functional limitation, or recent fractures)
  • Participation in yoga classes or similar mind body therapy within the last 3 months.
  • Uncontrolled infection or unstable clinical status as determined by the treating

研究者

相似试验